Off-label uses of Aflibercept, Ranibizumab and Dexamethasone implant for diabetic retinopathy in Turkey

Objective: Diabetic retinopathy (DRP) is the most common retinal vascular disease leading to blindness. There is limited data about the off-label drug use for DRP and diabetic macular edema (DME) in literature. The aim of the article was to evaluate the applications for off-label drug use in patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Yilmaz, Mevlut, Citirik, Mehmet, Rahmanlar, Hanife, Alkan, Ali, Gursoz, Hakki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Romanian Society of Ophthalmology 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773121/
https://www.ncbi.nlm.nih.gov/pubmed/36589330
http://dx.doi.org/10.22336/rjo.2022.56

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773121/
https://www.ncbi.nlm.nih.gov/pubmed/36589330
http://dx.doi.org/10.22336/rjo.2022.56

Ejemplares similares